Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 4/20 | 0.62 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | PROKR1 | Q8TCW9 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.40 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43079 | 0.96 | HTR2C (0.67) | HTR2CPTGDR2HSD11B1OPRL1KCNH2 | |
| SCHEMBL31469392 | 0.96 | HTR2C (0.67) | HTR2CPTGDR2HSD11B1OPRL1KCNH2 | |
| SCHEMBL29871435 | 0.93 | HTR2C (0.64) | HTR2CPTGDR2PTGS2NPC1RAB9A | |
| SCHEMBL8130416 | 0.93 | HTR2C (0.64) | HTR2CPTGDR2PTGS2NPC1RAB9A | |
| SCHEMBL1128179 | 0.93 | HTR2C (0.64) | HTR2CPTGDR2PTGS2NPC1RAB9A | |
| SCHEMBL1515219 | 0.91 | HTR2C (0.67) | HTR2CHSD11B1OPRL1KCNH2TRPV1 | |
| Biphenyl SCHEMBL9937258 | 0.88 | HTR2C (0.58) | HTR2CPTGDR2PTGS2NPC1RAB9A | |
| SCHEMBL1225741 | 0.86 | HTR2C (0.72) | HTR2COPRL1KCNH2TRPV1 | |
| SCHEMBL10621727 | 0.84 | HTR2C (0.55) | HTR2CPTGDR2HSD11B1TRPV1PROKR1 | |
| Hydrogen Peroxide SCHEMBL3679819 | 0.81 | PTGDR2 (0.55) | PTGDR2MEN1KMT2APTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105102119-B | process for preparing alkylated aromatic compounds | 埃克森美孚化学专利公司 | 2019-12-06 | — | — | CN | disclosed |
| US-10259759-B2 | Cyclohexylbenzene composition | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-04-16 | — | — | US | disclosed |
| US-9908829-B2 | Process for making phenol and/or cyclohexanone | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-03-06 | — | — | US | disclosed |
| US-20170057895-A1 | Phenol Composition | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-03-02 | — | — | US | disclosed |
| US-20170001930-A1 | Cyclohexylbenzene Composition | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-01-05 | — | — | US | disclosed |
| US-20160376212-A1 | Process for Making Cyclohexylbenzene and/or Phenol and/or Cyclohexanone | EXXONMOBIL CHEMICAL PATENTS INC. | 2016-12-29 | — | — | US | disclosed |
| US-20160376210-A1 | Process for Making Phenol and/or Cyclohexanone | EXXONMOBIL CHEMICAL PATENTS INC. | 2016-12-29 | — | — | US | disclosed |
| EP-3083538-A2 | PROCESS FOR MAKING PHENOL AND/OR CYCLOHEXANONE | ExxonMobil Chemical Patents Inc. (US) | 2016-10-26 | — | — | EP | disclosed |
| EP-3083539-A1 | PROCESS FOR MAKING CYCLOHEXYLBENZENE AND/OR PHENOL AND/OR CYCLOHEXANONE | ExxonMobil Chemical Patents Inc. (US) | 2016-10-26 | — | — | EP | disclosed |
| EP-3083530-A1 | CYCLOHEXYLBENZENE COMPOSITION | ExxonMobil Chemical Patents Inc. (US) | 2016-10-26 | — | — | EP | disclosed |
| WO-2015094952-A1 | PROCESS FOR MAKING CYCLOHEXYLBENZENE AND/OR PHENOL AND/OR CYCLOHEXANONE | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015094528-A1 | CYCLOHEXYLBENZENE COMPOSITION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015094530-A2 | PROCESS FOR MAKING PHENOL AND/OR CYCLOHEXANONE | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015094571-A1 | PHENOL COMPOSITION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-06-25 | — | — | WO | disclosed |
| WO-2012082229-A1 | COMPOSITION COMPRISING CYCLOHEXYLBENZENE AND 1 - PHENYL - 1 -METHYLCYCLOPENTANE AND USE THEREOF IN OXIDATION PROCESSES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-06-21 | — | — | WO | disclosed |
| US-4269734-A | A NICKEL (II) OR COPPER (II) PORPHINE COMPLEX ON A SUPPORT OF AN OXIDE OF MAGNESIUM OR CALCIUM AS CATALYST FOR THE PEROXIDATION OF CYCLOHEXYLBENZENE IN THE DARK | PHILLIPS PETROLEUM COMPANY (US) | 1981-05-26 | — | — | US | disclosed |
| US-4202992-A | Process for producing hydroperoxides | PHILLIPS PETROLEUM COMPANY (US) | 1980-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10259759-B2 | Cyclohexylbenzene composition | CYP1B1, CYP4B1, MCCC2 | HTR2C 1702/4885PTGDR2 1662/4885HSD11B1 561/4885 |
| US-20170001930-A1 | Cyclohexylbenzene Composition | CYP1B1, CYP4B1, MCCC2 | HTR2C 1702/4885PTGDR2 1662/4885HSD11B1 561/4885 |
| US-20170057895-A1 | Phenol Composition | CYP4B1, CYP26B1, CYP1B1 | HTR2C 1898/4885PTGDR2 1283/4885HSD11B1 358/4885 |
| US-20160376212-A1 | Process for Making Cyclohexylbenzene and/or Phenol and/or Cyclohexanone | HPD, CYP8B1, PAH | HTR2C 1332/4885PTGDR2 1889/4885HSD11B1 465/4885 |
| US-20160376210-A1 | Process for Making Phenol and/or Cyclohexanone | CYP4B1, CYP26B1, CYP1B1 | HTR2C 2120/4885PTGDR2 1807/4885HSD11B1 375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.